OPIOID INVOLVEMENT IN ALCOHOL DRINKING
阿片类药物参与饮酒
基本信息
- 批准号:2442145
- 负责人:
- 金额:$ 16.93万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1989
- 资助国家:美国
- 起止时间:1989-04-01 至 1999-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION: This research plan addresses the hypothesis that
alcohol-induced activation of the opioid system is a neurobiological
mechanism that contributes to high alcohol drinking. The goal of this
proposal is to determine whether receptor-selective opioid antagonists are
capable of blocking the initiation and maintenance of high alcohol drinking
in rats selectively bred for alcohol preference. To achieve this goal the
following specific aims will be pursued: 1. Determine whether chronic
administration of a mu and a delta receptor-selective antagonist, alone and
in combination, attenuates alcohol drinking after drinking has begun in rats
selectively bred for alcohol preference.
2. Determine whether chronic administration of a mu or a delta
receptor-selective antagonist prevents reinitiation of alcohol drinking
following cessation of chronic consumption (relapse) in rats selectively
bred for alcohol preference.
3. Determine whether chronic administration of a mu or a delta
receptor-selective antagonist prevents the initiation of alcohol drinking in
rats selectively bred for alcohol preference.
The proposed experiments will determine the potency of mu and delta
receptor-selective antagonists in attenuating alcohol intake and will
determine whether these antagonists primarily reduce the intake of alcohol
compared with the intake of food, water, and another preferred solution.
The experiments will be conducted using rats of the alcohol-preferring (P)
and high alcohol drinking (HAD) lines which are well suited for testing the
efficacy of agents that have the potential to reduce alcohol intake.
描述:本研究计划解决的假设是
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
janice C Froehlich其他文献
janice C Froehlich的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('janice C Froehlich', 18)}}的其他基金
Noradrenergic Agents As Potential New Pharmacotherapies for Alcohol Drinking
去甲肾上腺素能药物作为潜在的饮酒新药物疗法
- 批准号:
8610862 - 财政年份:2010
- 资助金额:
$ 16.93万 - 项目类别:
Noradrenergic Agents As Potential New Pharmacotherapies for Alcohol Drinking
去甲肾上腺素能药物作为潜在的饮酒新药物疗法
- 批准号:
8036093 - 财政年份:2010
- 资助金额:
$ 16.93万 - 项目类别:
Noradrenergic Agents As Potential New Pharmacotherapies for Alcohol Drinking
去甲肾上腺素能药物作为潜在的饮酒新药物疗法
- 批准号:
8230776 - 财政年份:2010
- 资助金额:
$ 16.93万 - 项目类别:
Noradrenergic Agents As Potential New Pharmacotherapies for Alcohol Drinking
去甲肾上腺素能药物作为潜在的饮酒新药物疗法
- 批准号:
8436334 - 财政年份:2010
- 资助金额:
$ 16.93万 - 项目类别:
Noradrenergic Agents As Potential New Pharmacotherapies for Alcohol Drinking
去甲肾上腺素能药物作为潜在的饮酒新药物疗法
- 批准号:
7917969 - 财政年份:2010
- 资助金额:
$ 16.93万 - 项目类别:
ALCOHOL WITHDRAWAL IN RAT LINES SELECTED FOR PREFERENCE
优先选择的大鼠系中的酒精戒断
- 批准号:
6948391 - 财政年份:1995
- 资助金额:
$ 16.93万 - 项目类别:














{{item.name}}会员




